focus -WSS

focus

author：fashion 2025-10-01 20:14:13 - browse：6461

Jamy Ard (left) and Robert Lustig (right) on the 2023 STAT Breakthrough Summit stage -- coverage from STAT — Obesity experts Jamy Ard (left) and Robert Lustig speak at a panel during the 2023 STAT Breakthrough Summit. Sarah Gonzalez for STAT

Amid rising demand for drugs like Wegovy, Ozempic, and Mounjaro that can lead to significant weight loss, some obesity experts are concerned about the drugs’ costs — both to patients’ finances and to their health.

Speaking at a panel on new obesity treatments at the STAT Breakthrough Summit in San Francisco on Thursday, one expert cited a large clinical trial for Wegovy that showed that about 40% of the weight participants lost was lean mass. Side effects like nausea, vomiting, and a possible link to rare cases of pancreatitis also still plague this newest class of drugs, which imitate the effects of a hormone called glucagon-like peptide 1 (GLP) that helps people feel full.

“That’s what starvation does. You lose equal amounts of muscle and fat,” said Robert Lustig, emeritus professor of pediatrics at the University of California, San Francisco. “If you’re a person 60 years old or over and you’re losing muscle, your risk of dying just went up exponentially. So we may be … robbing Peter to pay Paul.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Hollywood unions extend contract negotiations for actors
Next article： Ohio still needs to do more to protect the right to abortion

WSS

Trump lawyer welcomes Pence testifying in Jan. 6 trial, won't say if Trump will too

DeSantis and Newsom agree to Sean Hannity debate, then disagree on the rules

Ohio still needs to do more to protect the right to abortion

Trump lawyer welcomes Pence testifying in Jan. 6 trial, won't say if Trump will too

Readout LOUD Podcast: Lilly's obesity drug, the power of radiation

More people are opting for early dinners since the pandemic, says OpenTable CEO Debby Soo

knowledge

focus

focus

BioMarin wins approval for gene therapy to treat hemophilia A

Weight loss drugs should be covered by insurers, AMA says

Medical leaders decry Supreme Court decision on affirmative action

Bursting ice dam in Alaska highlights risks of glacial flooding around the globe

The high cost of giving birth even with insurance

Type 2 diabetes prevention programs work at large scale: study

Activists slam private health insurers over coverage restrictions

Biden will tout long

At least 13 dead in Texas as scorching temps continue

Cancer diagnosis changes perspective doctor, former hospital CEO

entertainment

Israel demolishes home of alleged Palestinian attacker, fueling West Bank tensions

Thousands in Haiti march to demand safety from violent gangs as killings and kidnappings soar

FDA reorg will put new emphasis on investigations, sources say

UnitedHealth sued over use of algorithm in Medicare Advantage plans

Readout Newsletter: Zepbound, Valneva's vaccine, and more

Ventyx halts psoriasis drug development after lackluster trial results

explore

entertainment

hotspot

focus